Latest posts
-
Continuous-Flow 3D Bioreactor Systems: Solving the Scalability Challenge in Clinical-Grade Exosome Manufacturing
The promise of exosome-based therapeutics has never been brighter. With over 150 clinical trials registered worldwide investigating extracellular vesicles, the bottleneck has shifted decisively from scientific validation to manufacturing scalability. The ability to produce clinical-grade exosomes in commercial quantities represents the defining challenge of this generation in bioprocessing. The Scale Problem: Why Traditional Methods Fall…